Ember Bio

Private

Boston-based biotech engineering AI-designed CAR-T cell therapies for solid tumor pediatric cancers.

Founders Sarah Kim

CEO Sarah Kim

Company

Founded

2024

Headquarters

Boston, United States

Financials

Total Funding

$12M

Sectors

Artificial Intelligence Biotech

emberbio.com

Funding History

1 round

Seed Aug 24, 2026

$12M

ARCH Venture Partners (Lead) Third Rock Ventures F-Prime Capital

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.